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Bile acids (BA) are signaling molecules with pleiotropic
paracrine and endocrine functions (for recent reviews
see [1-4] and references herein). Bile acids are involved
in the regulation of bile acid, glucose, lipid and energy
homeostasis and can modulate the immune response
both in the liver and in the intestine [1,2]. Furthermore,
bile acids can promote cell proliferation, cell differentia-
tion and liver regeneration [1-6]. However, especially
hydrophobic bile acids may also induce liver damage
through induction of programmed cell death (apoptosis)
as well as necrosis in hepatocytes [1,2]. Bile acid effects
in the liver are cell type and bile acid specific and are
facilitated through different bile acid sensing molecules,
comprising nuclear hormone receptors, G-protein
coupled receptors (GPCRs) as well as integrins and ion
channels [1,2].
The farnesoid X receptor (FXR, NR1H4) is a ligand
activated transcription factor responsive to different bile
acids and highly expressed in hepatocytes. FXR plays an
important role in the regulation of bile acid synthesis,
detoxification and secretion. Activation of FXR contri-
butes to liver regeneration following partial hepatectomy
[5] and alleviates liver injury in different animal models
of cholestatic liver disease [1,2].
TGR5 (Gpbar-1, M-Bar) is a GPCR responsive to var-
ious unconjugated and conjugated bile acids with taurine-
conjugated secondary bile acids, such as taurolithocholic
acid (TLC) and taurodeoxycholic acid (TDC), being the
most potent TGR5 ligands [1,2]. Expression of TGR5
mRNA is almost ubiquitously detected in human and
rodent tissues. In liver, TGR5 is found in sinusoidal
endothelial cells (SEC), Kupffer cells (KC), cholangiocytes,
gallbladder epithelial cells and gallbladder smooth muscle
cells [1-3]. Here, activation of TGR5 by bile acids can alter
hepatic microcirculation, modulate the immune response,
promote cholangiocyte secretion and induce gallbladder
filling [3]. The expression pattern in different non-
parenchymal cells of the liver as well as the anti-inflamma-
tory, anti-apoptotic, choleretic and proliferative functions
of TGR5 suggest a role for this bile acid receptor in liver
injury as well as in liver regeneration [1,3]. Mice with a
targeted deletion of TGR5 are more susceptible to develop
liver steatosis and hepatic inflammation than wildtype lit-
termates, but are protected from the formation of choles-
terol gallstones [3]. Using TGR5 specific agonists different
groups could demonstrate that activation of the receptor
reduces liver inflammation and steatohepatitis, thereby
improving liver function tests [3].
Aim of our studies is to elucidate the role of TGR5 in
bile acid induced liver damage and regeneration. TGR5
knockout and wildtype mice were fed ad libitum with a
bile acid containing diet for 7 days. Liver injury was
assessed by serum biochemistry and liver histology.
Cellular proliferation was made visible using immunohis-
tochemistry of liver sections and an antibody against
proliferating cell nuclear antigen (PCNA). Ductular pro-
liferation was assessed and quantified by cytokeratin
(CK)-19 immunofluorescence staining and confocal laser
scanning microscopy. Cholangiocytes were cultivated
from isolated ducts from livers of TGR5 wildtype and
knockout mice and cell proliferation was measured by
BrdU incorporation after stimulation with bile acids or
specific TGR5 agonists. The role of TGR5 downstream
signalling pathways was analyzed with different kinase
inhibitors. The generation of reactive oxygen species
(ROS) was measured using a fluorescent dye and shed-
ding of EGF was determined by an ELISA assay. Western
blotting was carried out to confirm the phosphorylation
of the EGFR and ERK1/2. Bile acid feeding resulted in
more elevated liver function tests in TGR5 knockout
mice as compared to their wildtype littermates on the
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same diet. Livers from TGR5 knockout mice fed with bile
acids for 4 days showed larger areas of hepatocytes
necrosis as livers from wildtype animals on the same diet.
In contrast, livers from bile acid-fed wildtype animals dis-
played increased PCNA-positive hepatocytes and cholan-
giocytes, as compared to the livers from the respective
knockout animals, indicating a rise in cell proliferation
following bile acid feeding in wildtype livers. Since TGR5
is highly expressed in cholangiocytes, we focused on
bile acid mediated cholangiocyte proliferation. While
the amount of CK-19 positive bile ducts was comparable
between TGR5 wildtype and knockout mice on chow
diet, a significant increase of bile duct proliferation as
measured by CK-19 staining was detected in livers from
wildtype mice following 7 days on CA diet as compared
to livers from TGR5 knockout mice on the same diet.
Incubation of isolated cultivated cholangiocytes from
TGR5 wildtype and knockout mice with taurolithocholic
acid (TLC 10 and 25 µM) or TGR5 specific agonists led
to a significantly increased cholangiocyte proliferation
exclusively in wildtype derived cells. Preincubation of
wildtype derived cholangiocytes with inhibitors of Src
kinases, epidermal growth factor receptor (EGFR) kinase
or ERK1/2 kinases significantly reduced TLC and TGR5
agonist mediated cell proliferation as measured by BrDU
incorporation. Treatment with inhibitors of ROS forma-
tion, such as N-acetylcystein or apocynin also suppressed
TLC dependent BrdU incorporation. In contrast, inhibi-
tion of adenylate cyclase by SQ22536 or dideoxyadeno-
sine showed no effect on TLC or TGR5 agonist mediated
cholangiocyte proliferation. Stimulation of wildtype
derived cholangiocytes with TLC and a TGR5 agonist
significantly elevated ROS formation. Increased shedding
of EGF was also detected after incubation of wildtype
cholangiocytes with TLC or the TGR5 agonist. Further-
more, TGR5 activation significantly induced tyrosine
phosphorylation of the EGFR at amino acid positions 845
and 1045 and increased ERK1 and ERK2 phosphoryla-
tion. Thus, bile acids mediate cholangiocyte proliferation
through a TGR5-ROS-Src-EGFR-ERK signaling pathway,
which is independent of adenylate cyclase activation.
In summary, TGR5 knockout mice show reduced
hepatocyte and cholangiocyte proliferation and more
pronounced liver injury in response to bile acid feeding.
This is in line with a recent publication, demonstrating
that liver regeneration is impaired in TGR5 knockout
mice following partial hepatectomy [6].
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